Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).

被引：0
|
作者：
Saran, Frank
Welsh, Liam
James, Allan
McBain, Catherine
Gattamaneni, Rao
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
[6] Boehringer Ingelheim Ltd, Bracknell, Berks, England
[7] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[8] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[9] Clatterbridge Canc Ctr NHS Fdn Trust, Bebington, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2036
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [2] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [3] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [4] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
  • [5] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [6] PHASE 1 STUDY EVALUATING ABT-414 WITH CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Gan, H. K.
    Fichtel, L.
    Lassman, A.
    Merrell, R.
    van den Bent, M. J.
    Kumthekar, P.
    Scott, A.
    Pedersen, M.
    Gomez, E.
    Fischer, J.
    Ames, W.
    Xiong, H.
    Dudley, M.
    Roberts-Rapp, L.
    Ansell, P. J.
    Holen, K.
    Reardon, D. A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Clarke, Jennifer
    Abrey, Lauren
    Karimi, Sasan
    Lassman, Andrew
    NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
  • [8] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Clarke, J. L.
    Abrey, L. E.
    Karimi, S.
    Lassman, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345